Pharmacovigilance benchmarking involves the systematic comparison of processes, performance metrics, and outcomes with those of other organizations or industry best practices. Qinecsa’s benchmarking service enables pharmaceutical companies and regulatory bodies to proactively identify areas for improvement, optimize resource allocation, and ultimately enhance drug safety.
Ensure compliance with regulatory standards, identify areas for improvement, and contribute to the collective advancement of pharmacovigilance on a broader scale.
Learning from others
Benchmarking allows organizations to evaluate their status, identify potential risks, and adopt best practices to align with evolving regulatory standards.
Stay up to date
Ongoing support to revisit benchmarks based on changing regulatory landscapes, technological advancements, and emerging therapeutic areas ensures that organizations stay ahead in addressing new challenges in drug safety.
Sharing anonymized data on different aspects of the pharma company can provide valuable insights into emerging risks and trends, enabling the industry to respond proactively to potential concerns.